Related references
Note: Only part of the references are listed.ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders
Jia Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Pierre Fenaux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet-induced obesity
Ruhang Tang et al.
SCIENCE ADVANCES (2020)
Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia
Chiharu Ojima et al.
CANCER SCIENCE (2020)
Skeletal muscle antagonizes antiviral CD8+ T cell exhaustion
Jingxia Wu et al.
SCIENCE ADVANCES (2020)
Muscle Wasting Diseases: Novel Targets and Treatments
Regula Furrer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice
Andreas Lodberg et al.
FASEB JOURNAL (2019)
Activin type II receptor signaling in cardiac aging and heart failure
Jason D. Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Role of Myokines in Regulating Skeletal Muscle Mass and Function
Jong Han Lee et al.
FRONTIERS IN PHYSIOLOGY (2019)
The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension
Masato Morikawa et al.
SCIENCE SIGNALING (2019)
Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease
R. S. Pearsall et al.
SCIENTIFIC REPORTS (2019)
Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer
Mayumi Harada et al.
CANCER SCIENCE (2019)
Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Roselyne Castonguay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation
Viet Q. Le et al.
EMBO JOURNAL (2018)
LOCALLY ACTING ACE-083 INCREASES MUSCLE VOLUME IN HEALTHY VOLUNTEERS
Chad E. Glasser et al.
MUSCLE & NERVE (2018)
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
Kieren D. Marini et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Inter-tissue communication in cancer cachexia
Josep M. Argiles et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
Andrea Iskenderian et al.
SKELETAL MUSCLE (2018)
MYOSTATIN INHIBITOR ACE-031 TREATMENT OF AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY: RESULTS OF A RANDOMIZED, PLACEBO- CONTROLLED CLINICAL TRIAL
Craig Campbell et al.
MUSCLE & NERVE (2017)
Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
Srinath Kasturirangan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Activin A more prominently regulates muscle mass in primates than does GDF8
Esther Latres et al.
NATURE COMMUNICATIONS (2017)
A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease
Eric Marty et al.
BONE (2017)
Structural basis for potency differences between GDF8 and GDF11
Ryan G. Walker et al.
BMC BIOLOGY (2017)
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
Amita Datta-Mannan et al.
MABS (2016)
Agonists and Antagonists of TGF-β Family Ligands
Chenbei Chang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
Masato Morikawa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration
Marc A. Egerman et al.
CELL METABOLISM (2015)
Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice
Claus Brandt et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Muscle wasting in disease: molecular mechanisms and promising therapies
Shenhav Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Timo Rath et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
Rajasekhar N. V. S. Suragani et al.
NATURE MEDICINE (2014)
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regenerations
Benjamin C. Yaden et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents
Chi-Sung Chiu et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII
Kengo Yamawaki et al.
PLOS ONE (2013)
Skeletal muscle aging and the mitochondrion
Matthew L. Johnson et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential
Amita Datta-Mannan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure
Ami C. Bautista et al.
AAPS JOURNAL (2012)
Structure of Myostatin.Follistatin-like 3 N-TERMINAL DOMAINS OF FOLLISTATIN-TYPE MOLECULES EXHIBIT ALTERNATE MODES OF BINDING
Jennifer N. Cash et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy
Emidio E. Pistilli et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif
Masato Morikawa et al.
NUCLEIC ACIDS RESEARCH (2011)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type
Samuel M. Cadena et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Delphine Meynard et al.
NATURE GENETICS (2009)
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Billy Andriopoulos et al.
NATURE GENETICS (2009)
Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity
Tingqing Guo et al.
PLOS ONE (2009)
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
Janaiah Kota et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
The Structure of FSTL3.Activin A Complex DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY
Robin Stamler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and Angiopoietin-1/Tie2 signalling
Yuka Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2008)
FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults
Abir Mukherjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins
Yisrael Sidis et al.
ENDOCRINOLOGY (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development
EB Harmon et al.
DEVELOPMENT (2004)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models
M Zeisberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum
JJ Hill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
Share Paper
